136 results
8-K
ATXI
Avenue Therapeutics Inc
29 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2:41pm
be no assurance that the Company will be able to do so.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
price of the split shares, there can be no assurance that our Common Stock will trade at a multiple of our current price, or that any price increase … difficulty in effecting such sales. Consequently, there can be no assurance that the reverse stock split will achieve the desired results outlined
8-K
vbq9gn8ewiz8y1op42t
15 Mar 24
Other Events
7:15am
PRE 14C
emzoq0 h7x0xn7j4d
8 Mar 24
Preliminary information
4:31pm
424B3
tg8tg4hv
2 Feb 24
Prospectus supplement
12:00am
8-K
qxt25b
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
8-K
EX-10.1
fn4qpj5kao
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
7itaa5ukye
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
mre90doclh2
2 Nov 23
Prospectus supplement with pricing info
9:00am